UK-37,248, A novel, selective thromboxane synthetase inhibitor with platelet anti-aggregatory and anti-thrombotic activity
- 1 July 1981
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 23 (1-2), 145-162
- https://doi.org/10.1016/0049-3848(81)90247-4
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Thromboxane release during pacing-induced angina pectoris: possible vasoconstrictor influence on the coronary vasculature.Circulation, 1980
- Detection of thromboxane B2 in peripheral blood of patients with Prinzmetal's anginaProstaglandins and Medicine, 1979
- Platelet adhesion and aggregation in diabetes mellitusMetabolism, 1979
- VASCULAR PROSTACYCLIN MAY BE REDUCED IN DIABETES IN MANThe Lancet, 1979
- UNSTABLE METABOLITES OF ARACHIDONIC ACID AND THEIR ROLE IN HAEMOSTASIS AND THROMBOSISBritish Medical Bulletin, 1978
- Biosynthesis of thromboxanes in human platelets. I. Characterization and assay of thromboxane systhetaseBiochemical and Biophysical Research Communications, 1977
- Arterial walls generate from prostaglandin endoperoxides a substance (prostaglandin X) which relaxes strips of mesenteric and coeliac arteries and inhibits platelet aggregationProstaglandins, 1976
- Arterial walls are protected against deposition of platelet thrombi by a substance (prostaglandin X) which they make from prostaglandin endoperoxidesProstaglandins, 1976
- An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregationNature, 1976
- Prostaglandin Endoperoxides IX. Characterization of Rabbit Aorta Contracting Substance (RCS) from Guinea Pig Lung and Human PlateletsActa Physiologica Scandinavica, 1975